immuni

Revolutionizing

cancer care

immUni Technologies is a pre-revenue, high-tech startup project spun out of ETH Zurich, Switzerland.

Solution

ImmUni technology uniquely combines biochemical and physical stimulation of immune cells. This innovative way of activating immune cells contributes to a significant enhancement of current therapeutic cell production steps, leading to shorter production time and better end product characteristics. ImmUni technology will enable to bringing these therapies on step closer to individuals in need.

Cancer Patient

+125%

Robust Activation

+90%

Optimized Gene Delivery

+120%

Faster Expansion

Patient Treatment

About us

ImmUni technology has been born at ETH Zurich from more than a decade of committed research. With an interdisciplinary team that combines biophysics, immunology and nanotechnology a novel platform has been invented, that addresses critical unmet needs of the currently booming advanced cell therapeutics sector. Compared to standard technology this innovative solution achieves a differential immune cell activation that allows for critical production time reduction and improved cell characteristics.

Our immUni team combines world leading science in mechano-immunology with entrepreneurial expertise in advanced cell therapies. Together with our established network of clinical collaborators we will be launching a first product applicable to CAR-T cell therapies research and development as well as clinical production.

It is our mission to evolve our research from bench to bedside to improve patients’ lives towards a future where cell advanced therapies will become available to every citizen in need.

Revolutionizing CAR-T cell therapy production

immUni disruptive technology overcomes major limitations of the traditional CAR-T cell production approaches, by achieving simultaneous reduction of production time and delivering a final CAR-T cell product with increased quality.

Play video

Based in Zurich Switzerland,
immUni Technologies is a pre-revenue, high-tech startup project spun out of ETH Zurich, Switzerland.

Technology

Based on our scientific discoveries from over 10 year of research, immUni spins out from ETH Zurich. We believe our unique solution can contribute advancing research and production of adoptive therapies.

Science

After more than a decade of committed research, immUni was born from a unique interdisciplinary approach combining biophysics, immunology and nanotechnology.